about
Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activityIdentification and structural definition of H5-specific CTL epitopes restricted by HLA-A*0201 derived from the H5N1 subtype of influenza A virusesInfluenza H1N1pdm-specific maternal antibodies offer limited protection against wild-type virus replication and influence influenza vaccination in ferretsADAMTS5 Is a Critical Regulator of Virus-Specific T Cell ImmunityA Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and FerretsHarnessing Local Immunity for an Effective Universal Swine Influenza VaccineSuperior in vitro stimulation of human CD8+ T-cells by whole virus versus split virus influenza vaccines.Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort StudyCombined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity.Acquired heterosubtypic antibodies in human immunity for avian H5N1 influenza.Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus.Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem.Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunityInfluenza-specific T cells from older people are enriched in the late effector subset and their presence inversely correlates with vaccine response.Liposome-coupled antigens are internalized by antigen-presenting cells via pinocytosis and cross-presented to CD8 T cells.Liposome-coupled peptides induce long-lived memory CD8 T cells without CD4 T cells.Heterosubtypic cross-protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administrationDissolving polymer microneedle patches for influenza vaccination.Quantitative and qualitative features of heterologous virus-vector-induced antigen-specific CD8+ T cells against Trypanosoma cruzi infection.Protocatechuic acid, a novel active substance against avian influenza virus H9N2 infection.Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine.Physical detection of influenza A epitopes identifies a stealth subset on human lung epithelium evading natural CD8 immunitySerological memory and long-term protection to novel H1N1 influenza virus after skin vaccinationMHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell responseCross-reactive human B cell and T cell epitopes between influenza A and B viruses.Ex vivo restimulation of human PBMC expands a CD3+CD4-CD8- γδ+ T cell population that can confound the evaluation of CD4 and CD8 T cell responses to vaccination.Q&A: What do we know about influenza and what can we do about it?Innate immune responses to influenza A H5N1: friend or foe?Cross-protection against drifted influenza viruses: options offered by adjuvanted and intradermal vaccinesEfficiency of pH-sensitive fusogenic polymer-modified liposomes as a vaccine carrier.Comparison of Heterosubtypic Protection in Ferrets and Pigs Induced by a Single-Cycle Influenza Vaccine.An Increased Frequency in HLA Class I Alleles and Haplotypes Suggests Genetic Susceptibility to Influenza A (H1N1) 2009 Pandemic: A Case-Control Study.
P2860
Q27309214-F4D91A15-0265-4F1F-9CF4-66C10458C7B0Q27658413-7D876E21-1D93-49DE-A0EA-F2C11292EBE0Q28395364-BEF00994-E468-4405-8F17-55FA0C419A10Q28553566-EC5733A0-B474-4EAA-908F-362D32E1741AQ30204020-82F38F3C-E1F9-419A-B624-2B2F46E2E5F2Q30234558-65040082-A135-4F42-A129-97BD816B4BF6Q30365243-E7DD3B79-4B9B-4034-84AE-FFEDA261026EQ30373419-16586330-F4C9-4112-B30A-6D2F01F20A18Q30374900-579908E3-4302-4645-BF12-A433518DDE30Q30384441-A24E5173-2D3B-48A8-832D-619280257FC4Q30388401-57A08E2A-1523-4EA9-A5A5-680763163894Q30416784-EE75C1A5-BCF7-449C-AB48-1173D984F7FBQ30421682-403DED8A-F711-438B-A5E2-FE1C1A5F5F72Q31030019-384F60A7-0576-4440-A042-124128D509EEQ33778353-3913A34C-0385-49EC-BB1D-3B4AFB88C795Q33802868-BB31526B-BCDE-4BD7-B74C-96DDB79AC4F3Q33958402-EDD92966-012B-4BA0-B6B8-F2262E9F69A4Q34049972-A45D3148-BC24-4A84-8654-F46A374AF287Q34188729-9D38E283-43C5-4E90-A0B6-DFEC35DAA0C3Q34388549-E141338C-A1F5-40CA-937C-B0C9E677872EQ34975686-936A4267-391A-401B-9A4A-ADC2B1D9E64EQ35128920-38D758B3-0A56-4AFD-A744-1758048E661BQ35129385-6E4F0DAB-615B-41D1-B771-82A389086F3CQ36381178-7F47E12E-4EA3-46B4-A2C5-2F27CCCAA596Q37053710-EFF6EB82-FC28-4D99-A3B9-16B5CA3E89ADQ37162910-036BE3D2-1317-4408-AC81-DEABC6255F35Q37330237-E23F87A8-1E14-4EF2-9435-F72CE2DABC20Q37346635-DA5026D4-7EA7-4394-8257-7453C32EA600Q37478319-40533104-CD92-4838-8D81-3825262FB86CQ53119249-B69FA38C-56F1-413C-AE8C-3354718BFED1Q54226450-D10B17EE-28D7-4567-A59D-01C9851C9D47Q55035559-2D65D039-EE33-4EBA-9116-292A7A181D7B
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Toward a broadly protective influenza vaccine
@ast
Toward a broadly protective influenza vaccine
@en
type
label
Toward a broadly protective influenza vaccine
@ast
Toward a broadly protective influenza vaccine
@en
prefLabel
Toward a broadly protective influenza vaccine
@ast
Toward a broadly protective influenza vaccine
@en
P2860
P356
P1476
Toward a broadly protective influenza vaccine
@en
P2860
P304
P356
10.1172/JCI37232
P407
P577
2008-10-01T00:00:00Z